Nomad Power Solutions, Inc. $NMAD
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Pharmaceutical Preparations
- Headquarters
- Boca Raton, FL
- Fiscal year end
- December 31
- Shares outstanding
- 16,101,068 [10-Q 2026-08-14]
What the company doesAI summary of filing
Nomad Power Solutions, Inc. (also known as Lixte Biotechnology Holdings, Inc.) is a clinical-stage biopharmaceutical and proton cancer therapy company. The company develops cancer therapies primarily focused on protein phosphatase 2A inhibitors, with its lead compound LB-100 currently in clinical trials for ovarian clear cell carcinoma, metastatic colon cancer, and soft tissue sarcoma. The company is also the majority shareholder of Liora Technologies Europe Ltd., which is developing the LiGHT System, an electronically controlled proton therapy linear accelerator for treating various cancers. The company is pre-revenue and has not commenced revenue-generating operations, relying on equity capital to fund operations. [10-K 2026-03-31]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | — | −$4.33M | −$3.44M | $12.67M | [10-Q 2026-08-14] |
| FY ended Dec 2025 | — | −$6.08M | −$3.07M | $5.11M | [10-K 2026-03-31] |
| FY ended Dec 2024 | — | −$3.59M | −$3.16M | $1.04M | [10-K 2026-03-31] |
- Quarterly cash burn
- −$1.72M
- Cash runway Estimate
- ~22.1 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-01 | 2,249,290 | [10-Q 2024-11-12] |
| 2025-03-14 | 2,684,074 | [10-K 2025-03-24] |
| 2025-04-30 | 2,684,074 | [10-Q 2025-05-12] |
| 2025-08-05 | 4,561,363 | [10-Q 2025-08-07] |
| 2025-11-05 | 5,704,200 | [10-Q 2025-11-12] |
| 2026-03-31 | 11,617,944 | [10-K 2026-03-31] |
| 2026-05-12 | 12,382,944 | [10-Q 2026-05-14] |
| 2026-08-10 | 16,101,068 | [10-Q 2026-08-14] |
- Shelf registration
- S-1 filed 2025-06-18; declared effective 2025-07-15 [S-1 2025-06-18]
Listing status
Current status: 3 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2025-04-18. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2025-04-18 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-04-18] |
| 2025-02-21 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-02-21] |
| 2024-10-23 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2024-10-23] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-07-01 | Stazzone Peter | grant | 50,000 | — | [4 2026-07-02] |
| 2026-07-01 | Sawyer Jason David | grant | 40,000 | — | [4 2026-07-02] |
| 2026-07-01 | Pursglove Geordan Garrett | grant | 350,000 | — | [4 2026-07-02] |
| 2026-07-01 | Primus Guy Warren | grant | 15,000 | — | [4 2026-07-02] |
| 2026-07-01 | Holloway Michael Andrew | grant | 15,000 | — | [4 2026-07-02] |
| 2026-07-01 | Felix Lourdes | grant | 30,000 | — | [4 2026-07-02] |
| 2026-05-29 | Porter Stuart D | grant | 25,000 | — | [4 2026-06-01] |
| 2026-04-15 | Pursglove Geordan Garrett | grant | 350,000 | — | [4 2026-04-17] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-10-06 | 8-K | Regulation FD disclosure |
| 2026-09-30 | 8-K | Material agreement entered; Unregistered sale of equity |
| 2026-08-14 | 10-Q | Quarterly report |
| 2026-07-31 | 13G | Beneficial ownership report (5%+ holder) |
| 2026-07-31 | 8-K | Regulation FD disclosure |
| 2026-07-27 | DEF 14A | Proxy statement |
| 2026-07-17 | PRE 14A | Proxy statement |
| 2026-07-10 | 8-K | Regulation FD disclosure |
| 2026-07-02 | 8-K | Material agreement entered; Acquisition or disposition completed; Unregistered sale of equity |
| 2026-06-18 | 8-K | Material agreement entered; Regulation FD disclosure |
| 2026-06-16 | 8-K | Material agreement entered; Unregistered sale of equity; Regulation FD disclosure |
| 2026-06-09 | 13G | Beneficial ownership report (5%+ holder) |
Alerts for $NMAD
Email me when Nomad Power Solutions, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.